0001567619-23-000698.txt : 20230106 0001567619-23-000698.hdr.sgml : 20230106 20230106181758 ACCESSION NUMBER: 0001567619-23-000698 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230104 FILED AS OF DATE: 20230106 DATE AS OF CHANGE: 20230106 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lanfear Dennis M CENTRAL INDEX KEY: 0001420822 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36721 FILM NUMBER: 23516160 MAIL ADDRESS: STREET 1: C/O COHERUS BIOSCIENCES, INC. STREET 2: 333 TWIN DOLPHIN DRIVE, SUITE 600 CITY: REDWOOD CITY STATE: CA ZIP: 94065 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Coherus BioSciences, Inc. CENTRAL INDEX KEY: 0001512762 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 273615821 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: C/O DENNIS M. LANFEAR STREET 2: 333 TWIN DOLPHIN DR, SUITE 600 CITY: REDWOOD CITY STATE: CA ZIP: 94065 BUSINESS PHONE: (650) 649-3530 MAIL ADDRESS: STREET 1: C/O DENNIS M. LANFEAR STREET 2: 333 TWIN DOLPHIN DR, SUITE 600 CITY: REDWOOD CITY STATE: CA ZIP: 94065 FORMER COMPANY: FORMER CONFORMED NAME: BioGenerics, Inc. DATE OF NAME CHANGE: 20110210 4 1 doc1.xml FORM 4 X0306 4 2023-01-04 0 0001512762 Coherus BioSciences, Inc. CHRS 0001420822 Lanfear Dennis M COHERUS BIOSCIENCES, INC. 333 TWIN DOLPHIN DRIVE, SUITE 600 REDWOOD CITY CA 94065 1 1 0 0 President & CEO Common Stock 2023-01-04 4 F 0 10905 9.87 D 568603 D Common Stock 432684 I By Trust Common Stock 86965 I By LLC Stock Option (Right to Buy) 10.37 2023-01-05 4 A 0 402500 0.00 A 2033-01-05 Common Stock 402500 402500 D Represents shares automatically withheld to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3. These shares are held by the Lanfear Revocable Trust, dated January 27, 2004, as restated, of which Reporting Person is a trustee. These shares are held by Lanfear Capital Advisors, LLC of which Reporting Person is President. The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from January 5, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. /s/ McDavid Stilwell, as Attorney-in-Fact for Dennis M. Lanfear 2023-01-06